Increase in glutamine-non-amidated muropeptides in the peptidoglycan of vancomycin-resistant Staphylococcus aureus strain Mu50

被引:121
作者
Hanaki, H
Labischinski, H
Inaba, Y
Kondo, N
Murakami, H
Hiramatsu, K
机构
[1] Juntendo Univ, Dept Bacteriol, Bunkyo Ku, Tokyo, Japan
[2] Bayer AG, Leverkusen, Germany
关键词
D O I
10.1093/jac/42.3.315
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The peptidoglycan compositions of vancomycin-resistant Staphylococcus aureus (VRSA) strain Mu50 (MIC 8 mg/L) and hetero-VRSA strain Mu3 (MIC 3 mg/L) were compared in order to understand the mechanism of vancomycin resistance. As compared with Mu3, the cell wall of Mu50 had increased amounts of glutamine-non-amidated muropeptides and decreased crosslinking of peptidoglycan with a greatly decreased dimer/monomer ratio of muropeptides, In agreement with this observation, the peptidoglycan of Mu50 bound 1.4 times more vancomycin than that of Mu3, The increase in non-amidated muropeptides and the reduced crosslinking of the cell-wall peptidoglycan may contribute to the vancomycin resistance by increasing the consumption of vancomycin by the pre-existing cell wall of Mu50 and reducing the amount of vancomycin reaching the cytoplasmic membrane where the vital targets of the antibiotic are situated.
引用
收藏
页码:315 / 320
页数:6
相关论文
共 23 条
[1]   GENETICS AND MECHANISMS OF GLYCOPEPTIDE RESISTANCE IN ENTEROCOCCI [J].
ARTHUR, M ;
COURVALIN, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (08) :1563-1571
[2]   AMANTADINE PROPHYLAXIS FOR HEALTH-CARE WORKERS - UNANSWERED QUESTIONS [J].
COX, RA .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 27 (01) :1-3
[3]   PHENOTYPIC AND GENOTYPIC HETEROGENEITY OF GLYCOPEPTIDE RESISTANCE DETERMINANTS IN GRAM-POSITIVE BACTERIA [J].
DUTKAMALEN, S ;
LECLERCQ, R ;
COUTANT, V ;
DUVAL, J ;
COURVALIN, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (10) :1875-1879
[4]   THE FEMC LOCUS OF STAPHYLOCOCCUS-AUREUS REQUIRED FOR METHICILLIN RESISTANCE INCLUDES THE GLUTAMINE-SYNTHETASE OPERON [J].
GUSTAFSON, J ;
STRASSLE, A ;
HACHLER, H ;
KAYSER, FH ;
BERGERBACHI, B .
JOURNAL OF BACTERIOLOGY, 1994, 176 (05) :1460-1467
[5]   Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50 [J].
Hanaki, H ;
Kuwahara-Arai, K ;
Boyle-Vavra, S ;
Daum, RS ;
Labischinski, H ;
Hiramatsu, K .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (02) :199-209
[6]   Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin [J].
Hiramatsu, K ;
Aritaka, N ;
Hanaki, H ;
Kawasaki, S ;
Hosoda, Y ;
Hori, S ;
Fukuchi, Y ;
Kobayashi, I .
LANCET, 1997, 350 (9092) :1670-1673
[7]   Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility [J].
Hiramatsu, K ;
Hanaki, H ;
Ino, T ;
Yabuta, K ;
Oguri, T ;
Tenover, FC .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (01) :135-136
[8]   RAPID AND SPECIFIC METHOD FOR THE DETERMINATION OF VANCOMYCIN IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY ON AN AMINOPROPYL COLUMN [J].
HOSOTSUBO, H .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1989, 487 (02) :421-427
[9]   Staphylococcal peptidoglycan interpeptide bridge biosynthesis: A novel antistaphylococcal target? [J].
Kopp, U ;
Roos, M ;
Wecke, J ;
Labischinski, H .
MICROBIAL DRUG RESISTANCE, 1996, 2 (01) :29-41
[10]  
NAKEL M, 1971, BIOCHEMISTRY-US, V10, P2170